MaaT Pharma's Series A Round

MaaT Pharma raised a round of funding on March 29, 2016. Investors include Biocodex.

MaaT Pharma is a biotechnology company created to treat important diseases, using the power of gut microbial ecology. MaaT stands for Microbiota as a Therapy and focuses on using the clinical promises…

Articles about MaaT Pharma's Series A Round: